Market Overview
The patient monitoring market covers a wide array of technologies designed to continuously or intermittently measure physiological parameters such as heart rate, blood pressure, oxygen saturation, and glucose levels. These solutions serve hospitals, ambulatory care centers, long-term care facilities, and increasingly, patients' homes. The market encompasses both traditional bedside monitors and emerging connected health platforms that enable clinicians to track patients remotely.
- •Market valued at approximately $59.66 billion in 2025, with projections reaching $112.48 billion by 2031
- •Encompasses cardiac, respiratory, blood glucose, and multi-parameter monitoring devices plus associated services
- •Includes remote patient monitoring devices segment valued at roughly $26.2 billion in 2025
Growth Drivers
The rising global burden of chronic diseases such as cardiovascular conditions, diabetes, and respiratory disorders is a primary catalyst, as these patients require continuous monitoring to manage their health effectively. An aging population with higher prevalence of comorbidities further amplifies demand for both hospital-based and home monitoring solutions. Additionally, the widespread adoption of telehealth and digital health infrastructure, accelerated by recent healthcare system transformations, is expanding the addressable market for connected monitoring devices.
- •Growing prevalence of chronic diseases and aging demographics driving demand for continuous health tracking
- •Rapid expansion of telehealth and digital health infrastructure lowering barriers to remote monitoring adoption
- •Advancements in wearable sensor technology and wireless connectivity enabling more sophisticated at-home care
Segmentation and Regional Analysis
The market is segmented by device type, including cardiac monitoring devices, respiratory monitors, blood glucose monitors, and multi-parameter monitoring systems, as well as by application across critical care, cardiology, neurology, and home healthcare settings. Services such as training and technical support also form a distinct segment. Geographically, North America currently leads the market due to advanced healthcare infrastructure and favorable reimbursement policies, while the Asia-Pacific region is expected to see the fastest growth driven by rising healthcare investment and large patient populations.
- •Major device categories include cardiac monitors, respiratory monitors, blood glucose monitors, and multi-parameter systems
- •North America leads in market share, with Asia-Pacific showing the strongest projected growth trajectory
- •Market also segmented by application into critical care, cardiology, home healthcare, and ambulatory settings
Trends and Outlook
What are the recent trends and outlook?
Artificial intelligence and machine learning are increasingly being integrated into monitoring devices to enable predictive analytics, automated alert systems, and early detection of clinical deterioration. The market is also seeing a pronounced shift toward interoperability, with devices designed to seamlessly share data across electronic health record systems and care teams. As healthcare systems continue prioritizing value-based care and reducing hospital readmissions, demand for continuous, real-time patient monitoring in both institutional and home settings is expected to sustain the market's robust growth trajectory through the decade.
- •AI-powered predictive analytics and automated alert systems are becoming standard features in advanced monitoring platforms
- •Strong momentum toward interoperability and integration with electronic health records and telehealth ecosystems
- •Value-based care models and hospital-at-home initiatives are accelerating adoption across multiple care settings
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.